Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0767 Cardiac Safety Study
NCT00543010Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Nov 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of MK-767 in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Nov 2002; status: terminated.
02
Drugs
MK-767
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00543010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543010.